Basecamp Wealth Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68K Buy
60
+37
+161% +$1.04K ﹤0.01% 1410
2026
Q1
$656 Buy
+23
New +$785 ﹤0.01% 1655

Other funds holding ATRC

Basecamp Wealth Advisors's ATRC Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its AtriCure (ATRC) stake by 161% in Q2 2026, buying an estimated $1.04K and bringing the position to 60 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Basecamp Wealth Advisors first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Basecamp Wealth Advisors held 60 shares of AtriCure worth $1.68K as of Q2 2026.
  • Basecamp Wealth Advisors bought 37 AtriCure shares in Q2 2026, an estimated $1.04K.
  • AtriCure made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1410 holding.
  • Basecamp Wealth Advisors first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.